Cargando…
Does the advertisement in Swiss pharmacy windows rest on evidence-based medicine? An observational study
OBJECTIVES: The aim of the study was to analyse the proportion of evidence-based medication displayed in pharmacies and compare it between the different linguistic regions of the country, at different times of the year to determine the amount of proven effective medications indirectly recommended to...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510886/ https://www.ncbi.nlm.nih.gov/pubmed/37730413 http://dx.doi.org/10.1136/bmjopen-2022-069186 |
_version_ | 1785108037684428800 |
---|---|
author | Känzig, Tanja Potterat, Melisa Corpataux, Thibault Ackermann, Simone Daniele Chaix, Edouard Gibilisco, Andrea Portmann, Aurelia Roberts, Judith Schaller, Amandine Wenger, Nicolas Wolffers, Oliver Beguelin, Charles Genne, Daniel |
author_facet | Känzig, Tanja Potterat, Melisa Corpataux, Thibault Ackermann, Simone Daniele Chaix, Edouard Gibilisco, Andrea Portmann, Aurelia Roberts, Judith Schaller, Amandine Wenger, Nicolas Wolffers, Oliver Beguelin, Charles Genne, Daniel |
author_sort | Känzig, Tanja |
collection | PubMed |
description | OBJECTIVES: The aim of the study was to analyse the proportion of evidence-based medication displayed in pharmacies and compare it between the different linguistic regions of the country, at different times of the year to determine the amount of proven effective medications indirectly recommended to the public in different parts of Switzerland. DESIGN: This is an observational study conducted by medical doctors in the department of internal medicine at the Spitalzentrum Biel, Switzerland. SETTING: The observation took place from July 2019 to May 2020. From a total of 1800 pharmacies in Switzerland, 68 different pharmacies were selected across the 3 main linguistic regions and the medication on display in their windows were examined 4 times a year regarding their efficacy. The displays of medication with or without evidence-based efficacy were described using absolute numbers and proportions and compared between the different linguistic regions at different seasons using χ(2). PARTICIPANTS: There were no human or animal participants involved in this study. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome is the proportion of medication displayed in pharmacy windows with a proven effectiveness in medical literature. The secondary outcome was the variability of the primary outcome over time (seasonal changes), over the different linguistic regions of Switzerland and between chains and privately owned pharmacies. RESULTS: We examined 970 medications and found that over the whole year, there is a high proportion of non-evidence-based drugs (56,9%) displayed in pharmacies. Swiss German cantons display significantly more non-evidence-based medications in winter. We found no statistical difference for other seasons or between chains and privately owned pharmacies. CONCLUSION: Pharmacies in Switzerland tend to display significantly more non-evidence-based drugs, thus indirectly recommending them to the public. In a time of necessary expansion of self-medication by the population, this could incite consumers to buy drugs without proven effectiveness. |
format | Online Article Text |
id | pubmed-10510886 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-105108862023-09-21 Does the advertisement in Swiss pharmacy windows rest on evidence-based medicine? An observational study Känzig, Tanja Potterat, Melisa Corpataux, Thibault Ackermann, Simone Daniele Chaix, Edouard Gibilisco, Andrea Portmann, Aurelia Roberts, Judith Schaller, Amandine Wenger, Nicolas Wolffers, Oliver Beguelin, Charles Genne, Daniel BMJ Open Public Health OBJECTIVES: The aim of the study was to analyse the proportion of evidence-based medication displayed in pharmacies and compare it between the different linguistic regions of the country, at different times of the year to determine the amount of proven effective medications indirectly recommended to the public in different parts of Switzerland. DESIGN: This is an observational study conducted by medical doctors in the department of internal medicine at the Spitalzentrum Biel, Switzerland. SETTING: The observation took place from July 2019 to May 2020. From a total of 1800 pharmacies in Switzerland, 68 different pharmacies were selected across the 3 main linguistic regions and the medication on display in their windows were examined 4 times a year regarding their efficacy. The displays of medication with or without evidence-based efficacy were described using absolute numbers and proportions and compared between the different linguistic regions at different seasons using χ(2). PARTICIPANTS: There were no human or animal participants involved in this study. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome is the proportion of medication displayed in pharmacy windows with a proven effectiveness in medical literature. The secondary outcome was the variability of the primary outcome over time (seasonal changes), over the different linguistic regions of Switzerland and between chains and privately owned pharmacies. RESULTS: We examined 970 medications and found that over the whole year, there is a high proportion of non-evidence-based drugs (56,9%) displayed in pharmacies. Swiss German cantons display significantly more non-evidence-based medications in winter. We found no statistical difference for other seasons or between chains and privately owned pharmacies. CONCLUSION: Pharmacies in Switzerland tend to display significantly more non-evidence-based drugs, thus indirectly recommending them to the public. In a time of necessary expansion of self-medication by the population, this could incite consumers to buy drugs without proven effectiveness. BMJ Publishing Group 2023-09-19 /pmc/articles/PMC10510886/ /pubmed/37730413 http://dx.doi.org/10.1136/bmjopen-2022-069186 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Public Health Känzig, Tanja Potterat, Melisa Corpataux, Thibault Ackermann, Simone Daniele Chaix, Edouard Gibilisco, Andrea Portmann, Aurelia Roberts, Judith Schaller, Amandine Wenger, Nicolas Wolffers, Oliver Beguelin, Charles Genne, Daniel Does the advertisement in Swiss pharmacy windows rest on evidence-based medicine? An observational study |
title | Does the advertisement in Swiss pharmacy windows rest on evidence-based medicine? An observational study |
title_full | Does the advertisement in Swiss pharmacy windows rest on evidence-based medicine? An observational study |
title_fullStr | Does the advertisement in Swiss pharmacy windows rest on evidence-based medicine? An observational study |
title_full_unstemmed | Does the advertisement in Swiss pharmacy windows rest on evidence-based medicine? An observational study |
title_short | Does the advertisement in Swiss pharmacy windows rest on evidence-based medicine? An observational study |
title_sort | does the advertisement in swiss pharmacy windows rest on evidence-based medicine? an observational study |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510886/ https://www.ncbi.nlm.nih.gov/pubmed/37730413 http://dx.doi.org/10.1136/bmjopen-2022-069186 |
work_keys_str_mv | AT kanzigtanja doestheadvertisementinswisspharmacywindowsrestonevidencebasedmedicineanobservationalstudy AT potteratmelisa doestheadvertisementinswisspharmacywindowsrestonevidencebasedmedicineanobservationalstudy AT corpatauxthibault doestheadvertisementinswisspharmacywindowsrestonevidencebasedmedicineanobservationalstudy AT ackermannsimonedaniele doestheadvertisementinswisspharmacywindowsrestonevidencebasedmedicineanobservationalstudy AT chaixedouard doestheadvertisementinswisspharmacywindowsrestonevidencebasedmedicineanobservationalstudy AT gibiliscoandrea doestheadvertisementinswisspharmacywindowsrestonevidencebasedmedicineanobservationalstudy AT portmannaurelia doestheadvertisementinswisspharmacywindowsrestonevidencebasedmedicineanobservationalstudy AT robertsjudith doestheadvertisementinswisspharmacywindowsrestonevidencebasedmedicineanobservationalstudy AT schalleramandine doestheadvertisementinswisspharmacywindowsrestonevidencebasedmedicineanobservationalstudy AT wengernicolas doestheadvertisementinswisspharmacywindowsrestonevidencebasedmedicineanobservationalstudy AT wolffersoliver doestheadvertisementinswisspharmacywindowsrestonevidencebasedmedicineanobservationalstudy AT beguelincharles doestheadvertisementinswisspharmacywindowsrestonevidencebasedmedicineanobservationalstudy AT gennedaniel doestheadvertisementinswisspharmacywindowsrestonevidencebasedmedicineanobservationalstudy |